---
document_datetime: 2023-09-21 22:01:40
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vafseo-epar-all-authorised-presentations_en.pdf
document_name: vafseo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0580755
conversion_datetime: 2025-12-22 13:31:51.692752
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|-------------|
| EU/1/23/1725/001 | VAFSEO            | 150 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 28 tablets  |
| EU/1/23/1725/002 | VAFSEO            | 150 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 98 tablets  |
| EU/1/23/1725/003 | VAFSEO            | 300 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 28 tablets  |
| EU/1/23/1725/004 | VAFSEO            | 300 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 98 tablets  |
| EU/1/23/1725/005 | VAFSEO            | 450 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 28 tablets  |
| EU/1/23/1725/006 | VAFSEO            | 450 mg     | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 98 tablets  |